News
Personalised Medicine and the Value of Molecular Diagnostics: Case Studies
18 December 2013
Progress in personalised medicine is slower than some had expected, partly because of the science and partly because of insufficient economic incentives, particularly for investing in…
Inconsistent Use of Cost-effectiveness Thresholds in NHS Scotland
12 December 2013
This study finds an apparent mismatch in the decision making approaches of the SMC and the NHS Boards. OHE today released a Research Paper on the…
Adjusting Patient Case Mix to Compare PROMs across Providers
10 December 2013
The model reported in this publication aims at valid comparisons across providers, despite variations in patient populations. A number of arguments support the attractive notion of…
Using MCDA to Assess the Value of Treatments for Rare Diseases
5 December 2013
A pilot study demonstrated the value of involving a range of stakeholders in MCDA for rare disease therapies. According to a study just published by the…
OHE Consulting Offers New Services in Patient-Reported Outcomes
4 December 2013
OHE Consulting is now offering our clients advice and analytical services on health outcomes and the use of patient-reported outcomes (PRO) data, building on the extensive…
Critique of Research Proposing to Lower NICE’s Cost-per-QALY Threshold to £12,936
2 December 2013
This paper counters recent research that recommended NICE lower its threshold from the current official £20,000-£30,000. Critique of CHE Research Paper 81: Methods for the Estimation…
Mike Herdman Appointed as OHE’s Head of Health Outcomes
25 November 2013
OHE’s extensive expertise in health outcomes will be further enhanced with the addition of Mike. OHE is delighted to announce the appointment of Mike Herdman as…
NICE Decisions: Cost-effectiveness is the Most Significant Predictor
21 November 2013
Using data for 1999-2011, this thorough analysis explores what has most influenced NICE’s decisions and whether this has changed. Established in 1999, the National Institute for…
OHE Study Projecting UK Medicines Expenditure Extended to 2018
18 November 2013
The extended analysis is outlined in the slide presentation in this post. PharmacoEconomics recently published OHE’s study projecting medicines expenditure in the UK to 2015. The…